Infections of Nonvalvular Cardiovascular Devices

Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases

Volumn 1, Issue , 2014, Pages 1041-1056

  Sohail, M Rizwan ^a   Wilson, Walter R ^a   Baddour, Larry M ^a  

^a Mayo Clinic   (United States)

Author keywords

Angioseal; Atrial septal defect; Biofilm; Cardiac device; Cardiac device infection; Cardiac resynchronization therapy device; Cardiac surgery; Cardiac suture line infections; Cardiovascular implantable electronic device (CIED); Closure device treatment of patent ductus arteriosus; Coagulase negative staphylococci (CoNS); Coronary artery stents; Coronary stent infection; CRT; Dacron carotid patches; Dacron graft; Dialysis graft; Hemodialysis graft; Hemodialysis prosthetic vascular grafts; Implantable cardioverter defibrillator (ICD); Inferior vena cava (IVC) filter; Intra aortic balloon pump (IABP); Invasive nonsurgical cardiologic procedures; Left ventricular assist device (LVAD); Nonvalvular; Pacemaker; Perclose; Peripheral vascular stents; PM; Prosthesis; Prosthesis infection; Prosthetic vascular graft; PVGI; S. aureus; Staphylococci; Staphylococcus aureus; Vascular closure devices; Vascular graft; Vena cava filters; Ventricular assist device (VAD); Ventricular septal defect

Indexed keywords

EID: 84944605105     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4557-4801-3.00084-9     Document Type: Chapter

References (221)

1. Baddour LM, Cha Y-M, Wilson WR Clinical practice. Infections of cardiovascular implantable electronic devices. N Engl J Med 2012, 367:842-849.
2. Sohail MR, Henrikson CA, Braid-Forbes MJ, et al. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med 2011, 171:1821-1828.
3. Greenspon AJ, Patel JD, Lau E, et al. 16-Year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States. J Am Coll Cardiol 2011, 58:1001-1006.
4. Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007, 49:1851-1859.
5. Lai KK, Fontecchio SA Infections associated with implantable cardioverter defibrillators placed transvenously and via thoracotomies: epidemiology, infection control, and management. Clin Infect Dis 1998, 27:265-269.
6. Mela T, McGovern BA, Garan H, et al. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter-defibrillator implants. Am J Cardiol 2001, 88:750-753.
7. Voigt A, Shalaby A, Saba S Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol 2006, 48:590-591.
8. Sohail MR, Uslan DZ, Khan AH, et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 2007, 45:166-173.
9. Uslan DZ, Sohail MR, St Sauver JL, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med 2007, 167:669-675.
10. Deleted in proofs.
11. Da Costa A, Lelievre H, Kirkorian G, et al. Role of the preaxillary flora in pacemaker infections: a prospective study. Circulation 1998, 97:1791-1795.
12. Klug D, Wallet F, Kacet S, et al. Involvement of adherence and adhesion Staphylococcus epidermidis genes in pacemaker lead-associated infections. J Clin Microbiol 2003, 41:3348-3350.
13. Donlan RM Biofilms and device-associated infections. Emerg Infect Dis 2001, 7:277-281.
14. Baddour LM, Bettmann MA, Bolger AF, et al. Nonvalvular cardiovascular device-related infections. Circulation 2003, 108:2015-2031.
15. Madhavan M, Sohail MR, Friedman PA, et al. Outcomes in patients with cardiovascular implantable electronic devices and bacteremia caused by gram-positive cocci other than Staphylococcus aureus. Circulation: Arrhythmia and Electrophysiology 2010, 3:639-645.
16. Uslan DZ, Dowsley TF, Sohail MR, et al. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing Clin Electrophysiol 2010, 33:407-413.
17. Obeid KM, Szpunar S, Khatib R Long-term outcomes of cardiovascular implantable electronic devices in patients with Staphylococcus aureus bacteremia. Pacing Clin Electrophysiol 2012, 35:961-965.
18. Chamis AL, Peterson GE, Cabell CH, et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 2001, 104:1029-1033.
19. Uslan DZ, Sohail MR, Friedman PA, et al. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. Clin Infect Dis 2006, 43:731-736.
20. Sohail MR, Hussain S, Le KY, et al. Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections. J Interv Card Electrophysiol 2011, 31:171-183.
21. Klug D, Balde M, Pavin D, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 2007, 116:1349-1355.
22. Al-Khatib SM, Lucas FL, Jollis JG, et al. The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries. J Am Coll Cardiol 2005, 46:1536-1540.
23. Duval X, Selton-Suty C, Alla F, et al. Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. Clin Infect Dis 2004, 39:68-74.
24. Bloom H, Heeke B, Leon A, et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 2006, 29:142-145.
25. Parsonnet V, Bernstein AD, Lindsay B Pacemaker-implantation complication rates: an analysis of some contributing factors. J Am Coll Cardiol 1989, 13:917-921.
26. Klug D, Vaksmann G, Jarwe M, et al. Pacemaker lead infection in young patients. Pacing Clin Electrophysiol 2003, 26:1489-1493.
27. Le KY, Sohail MR, Friedman PA, et al. Clinical features and outcomes of cardiovascular implantable electronic device infections due to staphylococcal species. Am J Cardiol 2012, 110:1143-1149.
28. Nagpal A, Baddour LM, Sohail MR Microbiology and pathogenesis of cardiovascular implantable electronic device infections. Circ Arrhythm Electrophysiol 2012, 5:433-441.
29. Chua JD, Wilkoff BL, Lee I, et al. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000, 133:604-608.
30. Oliva A, Nguyen BL, Mascellino MT, et al. Sonication of explanted cardiac implants improves microbial detection in cardiac device infections. J Clin Microbiol 2012, 51:496-502.
31. Rohacek M, Weisser M, Kobza R, et al. Bacterial colonization and infection of electrophysiological cardiac devices detected with sonication and swab culture. Circulation 2010, 121:1691-1697.
32. Le KY, Sohail MR, Friedman PA, et al. Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis. Pacing Clin Electrophysiol 2011, 34:450-459.
33. Sohail MR, Uslan DZ, Khan AH, et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc 2008, 83:46-53.
34. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633-638.
35. Greenspon AJ, Prutkin JM, Sohail MR, et al. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis. J Am Coll Cardiol 2012, 59:681-687.
36. Cacoub P, Leprince P, Nataf P, et al. Pacemaker infective endocarditis. Am J Cardiol 1998, 82:480-484.
37. Klug D, Lacroix D, Savoye C, et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 1997, 95:2098-2107.
38. Uslan DZ, Dowsley TF, Sohail MR, et al. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing Clin Electrophysiol 2010, 33:407-413.
39. Erba PA, Sollini M, Conti U, et al. Radiolabeled WBC scintigraphy in the diagnostic workup of patients with suspected device-related infections. JACC Cardiovascular imaging 2013, 6:1075-1086.
40. Sarrazin J-F, Philippon F, Tessier M, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol 2012, 59:1616-1625.
41. Arber N, Pras E, Copperman Y, et al. Pacemaker endocarditis: report of 44 cases and review of the literature. Medicine (Baltimore) 1994, 73:299-305.
42. Victor F, De Place C, Camus C, et al. Pacemaker lead infection: echocardiographic features, management, and outcome. Heart 1999, 81:82-87.
43. Vilacosta I, Sarria C, San Roman JA, et al. Usefulness of transesophageal echocardiography for diagnosis of infected transvenous permanent pacemakers. Circulation 1994, 89:2684-2687.
44. Rodriguez Y, Greenspon AJ, Sohail MR, Carrillo RG Cardiac device-related endocarditis complicated by spinal abscess. Pacing Clin Electrophysiol 2012, 35:269-274.
45. Bracke FA, Meijer A, van Gelder LM Pacemaker lead complications: when is extraction appropriate and what can we learn from published data?. Heart 2001, 85:254-259.
46. del Rio A, Anguera I, Miro JM, et al. Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome. Chest 2003, 124:1451-1459.
47. Parry G, Goudevenos J, Jameson S, et al. Complications associated with retained pacemaker leads. Pacing Clin Electrophysiol 1991, 14:1251-1257.
48. Le KY, Sohail MR, Friedman PA, et al. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm 2011, 8:1678-1685.
49. Meier-Ewert HK, Gray ME, John RM Endocardial pacemaker or defibrillator leads with infected vegetations: a single-center experience and consequences of transvenous extraction. Am Heart J 2003, 146:339-344.
50. Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007, 49:1851-1859.
51. Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 2010, 121:458-477.
52. Baddour LM Long-term suppressive antimicrobial therapy for intravascular device-related infections. Am J Med Sci 2001, 322:209-212.
53. Bertaglia E, Zerbo F, Zardo S, et al. Antibiotic prophylaxis with a single dose of cefazolin during pacemaker implantation: incidence of long-term infective complications. Pacing Clin Electrophysiol 2006, 29:29-33.
54. Da Costa A, Kirkorian G, Cucherat M, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation 1998, 97:1796-1801.
55. de Oliveira JC, Martinelli M, Nishioka SAD, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol 2009, 2:29-34.
56. Bloom HL, Constantin L, Dan D, et al. Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope. Pacing Clin Electrophysiol 2011, 34:133-142.
57. Kolek MJ, Dresen WF, Wells QS, Ellis CR Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients. Pacing Clin Electrophysiol 2013, 36:354-361.
58. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001, 345:1435-1443.
59. Kirklin JK, Naftel DC, Kormos RL, et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant 2010, 29:1-10.
60. Krishnamani R, DeNofrio D, Konstam MA Emerging ventricular assist devices for long-term cardiac support. Nat Rev Cardiol 2010, 7:71-76.
61. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009, 361:2241-2251. HeartMate II Investigators.
62. Kirklin JK, Naftel DC, Kormos RL, et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant 2010, 29:1-10.
63. Deleted in proofs.
64. Topkara VK, Kondareddy S, Malik F, et al. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. Ann Thorac Surg 2010, 90:1270-1277.
65. Piccione W Left ventricular assist device implantation: short and long-term surgical complications. J Heart Lung Transplant 2000, 19:S89-S94.
66. Malani PN, Dyke DB, Pagani FD, et al. Nosocomial infections in left ventricular assist device recipients. Clin Infect Dis 2002, 34:1295-1300.
67. Gordon SM, Schmitt SK, Jacobs M, et al. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Ann Thorac Surg 2001, 72:725-730.
68. Ankersmit HJ, Edwards NM, Schuster M, et al. Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95. Circulation 1999, 100:II211-II215.
69. Itescu S, Ankersmit JH, Kocher AA, et al. Immunobiology of left ventricular assist devices. Prog Cardiovasc Dis 2000, 43:67-80.
70. Zierer A, Melby SJ, Voeller RK, et al. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg 2007, 84:515-520.
71. Simon D, Fischer S, Grossman A, et al. Left ventricular assist device-related infection: treatment and outcome. Clin Infect Dis 2005, 40:1108-1115.
72. Deleted in proofs.
73. Goldberg SP, Baddley JW, Aaron MF, et al. Fungal infections in ventricular assist devices. ASAIO J 2000, 46:S37-S40.
74. Baradarian S, Stahovich M, Krause S, et al. Case series: clinical management of persistent mechanical assist device driveline drainage using vacuum-assisted closure therapy. ASAIO J 2006, 52:354-356.
75. Sinha P, Chen JM, Flannery M, et al. Infections during left ventricular assist device support do not affect post transplant outcomes. Circulation 2000, 102:III194-III199.
76. Chinn R, Dembitsky W, Eaton L, et al. Multicenter experience: prevention and management of left ventricular assist device infections. ASAIO J 2005, 51:461-470.
77. Choi L, Choudhri AF, Pillarisetty VG, et al. Development of an infection-resistant LVAD driveline: a novel approach to the prevention of device-related infections. J Heart Lung Transplant 1999, 18:1103-1110.
78. Siegenthaler MP, Martin J, Pernice K, et al. The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device. Eur J Cardiothorac Surg 2003, 23:748-755.
79. Pae WE, Connell JM, Adelowo A, et al. Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe. J Heart Lung Transplant 2007, 26:219-229.
80. Oderich GS, Panneton JM Aortic graft infection: what have we learned during the last decades?. Acta Chir Belg 2002, 102:7-13.
81. Valentine RJ Diagnosis and management of aortic graft infection. Semin Vasc Surg 2001, 14:292-301.
82. Hallett JW, Marshall DM, Petterson TM, et al. Graft-related complications after abdominal aortic aneurysm repair: reassurance from a 36-year population-based experience. J Vasc Surg 1997, 25:277-286.
83. Bandyk DF, Berni GA, Thiele BL, et al. Aortofemoral graft infection due to Staphylococcus epidermidis. Arch Surg 1984, 119:102-108.
84. Legout L, Sarraz-Bournet B, D'Elia PV, et al. Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study. Clin Microbiol Infect 2011, 18:352-358.
85. Seeger JM Management of patients with prosthetic vascular graft infection. Am Surg 2000, 66:166-177.
86. Chaudhary R, Simmons RL Pathogenesis of vascular graft infections. J Vasc Surg 1991, 13:755-756.
87. Bandyk DF, Novotney ML, Back MR, et al. Expanded application of in situ replacement for prosthetic graft infection. J Vasc Surg 2001, 34:411-420.
88. Antonios VS, Noel AA, Steckelberg JM, et al. Prosthetic vascular graft infection: a risk factor analysis using a case-control study. J Infect 2006, 53:49-55.
89. Stewart AH, Eyers PS, Earnshaw JJ Prevention of infection in peripheral arterial reconstruction: a systematic review and meta-analysis. J Vasc Surg 2007, 46:148-155.
90. Vogel TR, Symons R, Flum DR The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg 2008, 47:264-269.
91. Siracuse JJ, Nandivada P, Giles KA, et al. Prosthetic graft infections involving the femoral artery. J Vasc Surg 2013, 57:700-705.
92. Deleted in proofs.
93. Pitsch RJ, Lawrence PF Natural history of graft infections. Vascular Graft Infections 1994, 31-42. Futura, Armonk, NY. T.J. Bunt (Ed.).
94. Shahidi S, Eskil A, Lundof E, et al. Detection of abdominal aortic graft infection: comparison of magnetic resonance imaging and indium-labeled white blood cell scanning. Ann Vasc Surg 2007, 21:586-592.
95. Orton DF, LeVeen RF, Saigh JA, et al. Aortic prosthetic graft infections: radiologic manifestations and implications for management. Radiographics 2000, 20:977-993.
96. Yeager RA, Porter JM Arterial and prosthetic graft infection. Ann Vasc Surg 1992, 6:485-491.
97. Khaja MS, Sildiroglu O, Hagspiel K, et al. Prosthetic vascular graft infection imaging. Clin Imaging 2013, 37:239-244.
98. Lauwers P, Van den Broeck S, Carp L, et al. The use of positron emission tomography with (18)F-fluorodeoxyglucose for the diagnosis of vascular graft infection. Angiology 2007, 58:717-724.
99. Keidar Z, Engel A, Hoffman A, et al. Prosthetic vascular graft infection: the role of 18F-FDG PET/CT. J Nucl Med 2007, 48:1230-1236.
100. Bruggink JLM, Glaudemans AWJM, Saleem BR, et al. Accuracy of FDG-PET-CT in the diagnostic work-up of vascular prosthetic graft infection. Eur J Vasc Endovasc Surg 2010, 40:348-354.
101. Bunt TJ Vascular graft infections: an update. Cardiovasc Surg 2001, 9:225-233.
102. Saleem BR, Meerwaldt R, Tielliu IFJ, et al. Conservative treatment of vascular prosthetic graft infection is associated with high mortality. Am J Surg 2010, 200:47-52.
103. Igari K, Kudo T, Toyofuku T, et al. Treatment strategies for aortic and peripheral prosthetic graft infection. Surg Today 2014, 44:466-471.
104. Angle N, Freischlag JA Prosthetic graft infections. Vascular Surgery: A Comprehensive Review 2002, 741-750. WB Saunders, Philadelphia. 6th ed. W.S. Moore (Ed.).
105. Zetrenne E, McIntosh BC, McRae MH, et al. Prosthetic vascular graft infection: a multi-center review of surgical management. Yale J Biol Med 2007, 80:113-121.
106. Aavik A, Lieberg J, Kals J, et al. Ten years' experience of treating aorto-femoral bypass graft infection with venous allografts. Eur J Vasc Endovasc Surg 2008, 36:432-437.
107. Chiesa R, Astore D, Frigerio S, et al. Vascular prosthetic graft infection: epidemiology, bacteriology, pathogenesis and treatment. Acta Chir Belg 2002, 102:238-247.
108. O' Connor S, Andrew P, Batt M, et al. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg 2006, 44:38-45.
109. Stevenson KB, Hannah EL, Lowder CA, et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 2002, 39:549-555.
110. Tokars JI, Miller ER, Stein G New national surveillance system for hemodialysis-associated infections: initial results. Am J Infect Control 2002, 30:288-295.
111. Schanzer A, Ciaranello AL, Schanzer H Brachial artery ligation with total graft excision is a safe and effective approach to prosthetic arteriovenous graft infections. J Vasc Surg 2008, 48:655-658.
112. Nassar GM, Ayus JC Infectious complications of the hemodialysis access. Kidney Int 2001, 60:1-13.
113. Anderson JE, Chang AS, Anstadt MP Polytetrafluo-roethylene hemoaccess site infections. ASAIO J 2000, 46:S18-S21.
114. Nassar GM, Ayus JC Infectious complications of old nonfunctioning arteriovenous grafts in renal transplant recipients: a case series. Am J Kidney Dis 2002, 40:832-836.
115. Ayus JC, Sheikh-Hamad D Silent infection in clotted hemodialysis access grafts. J Am Soc Nephrol 1998, 9:1314-1317.
116. McKenna PJ, Leadbetter MG Salvage of chronically exposed Gore-Tex vascular access grafts in the hemodialysis patient. Plast Reconstr Surg 1988, 82:1046-1051.
117. NKF-DOQI Clinical Practice Guidelines for Vascular Access V. Management of complications: optimal approaches for treating complications. Am J Kidney Dis 2001, 37(suppl 1):S163.
118. Feldman HI, Held PJ, Hutchinson JT, et al. Hemodialysis vascular access morbidity in the United States. Kidney Int 1993, 43:1091-1096.
119. Tonnessen BH, Money SR Embracing the fistula first national vascular access improvement initiative. J Vasc Surg 2005, 42:585-586.
120. Shinefield H, Black S, Fattom A, et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 2002, 346:491-496.
121. Boelaert JR, Van Landuyt HW, Gordts BZ, et al. Nasal and cutaneous carriage of Staphylococcus aureus in hemodialysis patients: the effect of nasal mupirocin. Infect Control Hosp Epidemiol 1996, 17:809-811.
122. Laupland KB, Conly JM Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin Infect Dis 2003, 37:933.
123. Shea KW, Schwartz RK, Gambino AT, et al. Bacteremia associated with percutaneous transluminal coronary angioplasty. Cathet Cardiovasc Diagn 1995, 36:5-9.
124. Banai S, Selitser V, Keren A, et al. Prospective study of bacteremia after cardiac catheterization. Am J Cardiol 2003, 92:1004-1007.
125. Munoz P, Blanco JR, Rodriguez-Creixems M, et al. Bloodstream infections after invasive nonsurgical cardiologic procedures. Arch Intern Med 2001, 161:2110-2115.
126. Samore MH, Wessolossky MA, Lewis SM, et al. Frequency, risk factors, and outcome for bacteremia after percutaneous transluminal coronary angioplasty. Am J Cardiol 1997, 79:873-877.
127. Ramsdale DR, Aziz S, Newall N, et al. Bacteremia following complex percutaneous coronary intervention. J Invasive Cardiol 2004, 16:632-634.
128. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001, 32:1249-1272.
129. Marso SP, Ellis SG, Raymond R Intracoronary stenting: an overview for the clinician. Cleve Clin J Med 1999, 66:434-442.
130. James E, Broadhurst P, Simpson A, et al. Bacteraemia complicating coronary artery stenting. J Hosp Infect 1998, 38:154-155.
131. Garg RK, Sear JE, Hockstad ES Spontaneous coronary artery perforation secondary to a sirolimus-eluting stent infection. J Invasive Cardiol 2007, 19:E303-E306.
132. Gonda E, Edmundson A, Mann T Late coronary stent infection: a unique complication after drug-eluting stent implantation. J Invasive Cardiol 2007, 19:E307-E308.
133. Alfonso F, Moreno R, Vergas J Fatal infection after rapamycin eluting coronary stent implantation. Heart 2005, 91:e51.
134. Singh H, Singh C, Aggarwal N, et al. Mycotic aneurysm of left anterior descending artery after sirolimus-eluting stent implantation: a case report. Catheter Cardiovasc Interv 2005, 65:282-285.
135. Elieson M, Mixon T, Carpenter J Coronary stent infections: a case report and literature review. Tex Heart Inst J 2012, 39:884-889.
136. Hoffman M, Baruch R, Kaplan E, et al. Coronary stent bacterial infection with multiple organ septic emboli. Eur J Intern Med 2005, 16:123-125.
137. Myles O, Thomas WJ, Daniels JT, et al. Infected endovascular stents managed with medical therapy alone. Catheter Cardiovasc Interv 2000, 51:471-476.
138. Gordon GI, Vogelzang RL, Curry RH, et al. Endovascular infection after renal artery stent placement. J Vasc Interv Radiol 1996, 7:669-672.
139. Ducasse E, Calisti A, Speziale F, et al. Aortoiliac stent graft infection: current problems and management. Ann Vasc Surg 2004, 18:521-526.
140. Dosluoglu HH, Curl GR, Doerr RJ, et al. Stent-related iliac artery and iliac vein infections: two unreported presentations and review of the literature. J Endovasc Ther 2001, 8:202-209.
141. Liapis CD, Petrikkos GL, Paraskevas KI, et al. External iliac artery stent mucormycosis in a renal transplant patient. Ann Vasc Surg 2006, 20:253-257.
142. Darouiche RO Treatment of infections associated with surgical implants. N Engl J Med 2004, 350:1422-1429.
143. Saratzis N, Saratzis A, Melas N, et al. Aortoduodenal fistulas after endovascular stent-graft repair of abdominal aortic aneurysms: single-center experience and review of the literature. J Endovasc Ther 2008, 15:441-448.
144. Whitton Hollis H, Rehring TF Femoral endarteritis associated with percutaneous suture closure: new technology, challenging complications. J Vasc Surg 2003, 38:83-87.
145. Sohail MR, Khan AH, Holmes DR, et al. Infectious complications of percutaneous vascular closure devices. Mayo Clin Proc 2005, 80:1011-1015.
146. Collier PE, Liebler GA, Park SB, et al. Is percutaneous insertion of the intra-aortic balloon pump through the femoral artery the safest technique?. J Vasc Surg 1986, 3:629-634.
147. Eltchaninoff H, Dimas AP, Whitlow PL Complications associated with percutaneous placement and use of intraaortic balloon counterpulsation. Am J Cardiol 1993, 71:328-332.
148. Lazar JM, Ziady GM, Dummer SJ, et al. Outcome and complications of prolonged intraaortic balloon counterpulsation in cardiac patients. Am J Cardiol 1992, 69:955-958.
149. Aksnes J, Abdelnoor M, Berge V, et al. Risk factors of septicemia and perioperative myocardial infarction in a cohort of patients supported with intra-aortic balloon pump (IABP) in the course of open heart surgery. Eur J Cardiothorac Surg 1993, 7:153-157.
150. Kantrowitz A, Wasfie T, Freed PS, et al. Intraaortic balloon pumping 1967 through 1982: analysis of complications in 733 patients. Am J Cardiol 1986, 57:976-983.
151. Villarino ME, Jarvis WR, O' Hara C, et al. Epidemic of Serratia marcescens bacteremia in a cardiac intensive care unit. J Clin Microbiol 1989, 27:2433-2436.
152. Rutala WA, Weber DJ, Thomann CA, et al. An outbreak of Pseudomonas cepacia bacteremia associated with a contaminated intra-aortic balloon pump. J Thorac Cardiovasc Surg 1988, 96:157-161.
153. Crystal E, Borer A, Gilad J, et al. Incidence and clinical significance of bacteremia and sepsis among cardiac patients treated with intra-aortic balloon counterpulsation pump. Am J Cardiol 2000, 86:1281-1284.
154. Greenfield LJ, Proctor MC Filter complications and their management. Semin Vasc Surg 2000, 13:213-216.
155. Streiff MB Vena caval filters: a comprehensive review. Blood 2000, 95:3669-3677.
156. Millward SF, Peterson RA, Moher D, et al. LGM (Vena Tech) vena caval filter: experience at a single institution. J Vasc Interv Radiol 1994, 5:351-356.
157. Herbiere P, Courouble Y, Bourgeois P, et al. Lumbar spondylodiscitis after insertion of a Mobin-Uddin caval "umbrella" filter. Nouv Presse Med 1981, 10:3715-3716.
158. Lin M, Soo TB, Horn LC Successful retrieval of infected Gunther Tulip IVC filter. J Vasc Interv Radiol 2000, 11:1341-1343.
159. Meda MS, Lopez AJ, Guyot A Candida inferior vena cava filter infection and septic thrombophlebitis. Br J Radiol 2007, 80:e48-e49.
160. Rizzo A, Hertzer NR, O'Hara PJ, et al. Dacron carotid patch infection: a report of eight cases. J Vasc Surg 2000, 32:602-606.
161. Asciutto G, Geier B, Marpe B, et al. Dacron patch infection after carotid angioplasty: a report of 6 cases. Eur J Vasc Endovasc Surg 2007, 33:55-57.
162. Rockman CB, Su WT, Domenig C, et al. Postoperative infection associated with polyester patch angioplasty after carotid endarterectomy. J Vasc Surg 2003, 38:251-256.
163. El-Sabrout R, Reul G, Cooley DA Infected postcarotid endarterectomy pseudoaneurysms: retrospective review of a series. Ann Vasc Surg 2000, 14:239-247.
164. Krishnan S, Clowes AW Dacron patch infection after carotid endarterectomy: case report and review of the literature. Ann Vasc Surg 2006, 20:672-677.
165. Naylor AR, Payne D, London NJ, et al. Prosthetic patch infection after carotid endarterectomy. Eur J Vasc Endovasc Surg 2002, 23:11-16.
166. Sternbergh WC Regarding "Dacron carotid patch infection: a report of eight cases. J Vasc Surg 2001, 33:663-664.
167. McHenry MC, Longworth DL, Rehm SJ, et al. Infections of the cardiac suture line after left ventricular surgery. Am J Med 1988, 85:292-300.
168. Wellens F, Vanermen H Treatment of the infected cardiac suture line. J Card Surg 1988, 3:109-118.
169. Danias PG, Lehman T, Kartis T, et al. Cardiocutaneous fistula. Heart 1999, 81:325-326.
170. Knauth AL, Lock JE, Perry SB, et al. Transcatheter device closure of congenital and postoperative residual ventricular septal defects. Circulation 2004, 110:501-507.
171. Bullock AM, Menahem S, Wilkinson JL Infective endocarditis on an occluder closing an atrial septal defect. Cardiol Young 1999, 9:65-67.
172. Goldstein JA, Beardslee MA, Xu H, et al. Infective endocarditis resulting from CardioSEAL closure of a patent foramen ovale. Catheter Cardiovasc Interv 2002, 55:217-221.
173. Sohail MR, Henrikson CA, Braid-Forbes MJ, et al. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med 2011, 171:1821-1828.
174. Greenspon AJ, Patel JD, Lau E, et al. 16-Year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States. J Am Coll Cardiol 2011, 58:1001-1006.
175. Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007, 49:1851-1859.
176. Uslan DZ, Sohail MR, St Sauver JL, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med 2007, 167:669-675.
177. Madhavan M, Sohail MR, Friedman PA, et al. Outcomes in patients with cardiovascular implantable electronic devices and bacteremia caused by gram-positive cocci other than Staphylococcus aureus. Circulation: Arrhythmia and Electrophysiology 2010, 3:639-645.
178. Uslan DZ, Dowsley TF, Sohail MR, et al. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing Clin Electrophysiol 2010, 33:407-413.
179. Uslan DZ, Sohail MR, Friedman PA, et al. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. Clin Infect Dis 2006, 43:731-736.
180. Greenspon AJ, Prutkin JM, Sohail MR, et al. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis. J Am Coll Cardiol 2012, 59:681-687.
181. Le KY, Sohail MR, Friedman PA, et al. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm 2011, 8:1678-1685.
182. Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 2010, 121:458-477.
183. de Oliveira JC, Martinelli M, Nishioka SAD, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol 2009, 2:29-34.
184. Kolek MJ, Dresen WF, Wells QS, Ellis CR Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients. Pacing Clin Electrophysiol 2013, 36:354-361.
185. Kirklin JK, Naftel DC, Kormos RL, et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant 2010, 29:1-10.
186. Topkara VK, Kondareddy S, Malik F, et al. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. Ann Thorac Surg 2010, 90:1270-1277.
187. Gordon SM, Schmitt SK, Jacobs M, et al. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Ann Thorac Surg 2001, 72:725-730.
188. Simon D, Fischer S, Grossman A, et al. Left ventricular assist device-related infection: treatment and outcome. Clin Infect Dis 2005, 40:1108-1115.
189. Chinn R, Dembitsky W, Eaton L, et al. Multicenter experience: prevention and management of left ventricular assist device infections. ASAIO J 2005, 51:461-470.
190. Hallett JW, Marshall DM, Petterson TM, et al. Graft-related complications after abdominal aortic aneurysm repair: reassurance from a 36-year population-based experience. J Vasc Surg 1997, 25:277-286.
191. Legout L, Sarraz-Bournet B, D'Elia PV, et al. Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study. Clin Microbiol Infect 2011, 18:352-358.
192. Bandyk DF, Novotney ML, Back MR, et al. Expanded application of in situ replacement for prosthetic graft infection. J Vasc Surg 2001, 34:411-420.
193. Antonios VS, Noel AA, Steckelberg JM, et al. Prosthetic vascular graft infection: a risk factor analysis using a case-control study. J Infect 2006, 53:49-55.
194. Stewart AH, Eyers PS, Earnshaw JJ Prevention of infection in peripheral arterial reconstruction: a systematic review and meta-analysis. J Vasc Surg 2007, 46:148-155.
195. Siracuse JJ, Nandivada P, Giles KA, et al. Prosthetic graft infections involving the femoral artery. J Vasc Surg 2013, 57:700-705.
196. Shahidi S, Eskil A, Lundof E, et al. Detection of abdominal aortic graft infection: comparison of magnetic resonance imaging and indium-labeled white blood cell scanning. Ann Vasc Surg 2007, 21:586-592.
197. Khaja MS, Sildiroglu O, Hagspiel K, et al. Prosthetic vascular graft infection imaging. Clin Imaging 2013, 37:239-244.
198. Bruggink JLM, Glaudemans AWJM, Saleem BR, et al. Accuracy of FDG-PET-CT in the diagnostic work-up of vascular prosthetic graft infection. Eur J Vasc Endovasc Surg 2010, 40:348-354.
199. Saleem BR, Meerwaldt R, Tielliu IFJ, et al. Conservative treatment of vascular prosthetic graft infection is associated with high mortality. Am J Surg 2010, 200:47-52.
200. Zetrenne E, McIntosh BC, McRae MH, et al. Prosthetic vascular graft infection: a multi-center review of surgical management. Yale J Biol Med 2007, 80:113-121.
201. Aavik A, Lieberg J, Kals J, et al. Ten years' experience of treating aorto-femoral bypass graft infection with venous allografts. Eur J Vasc Endovasc Surg 2008, 36:432-437.
202. Stevenson KB, Hannah EL, Lowder CA, et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 2002, 39:549-555.
203. Schanzer A, Ciaranello AL, Schanzer H Brachial artery ligation with total graft excision is a safe and effective approach to prosthetic arteriovenous graft infections. J Vasc Surg 2008, 48:655-658.
204. Ayus JC, Sheikh-Hamad D Silent infection in clotted hemodialysis access grafts. J Am Soc Nephrol 1998, 9:1314-1317.
205. NKF-DOQI Clinical Practice Guidelines for Vascular Access V. Management of complications: optimal approaches for treating complications. Am J Kidney Dis 2001, 37(suppl 1):S163.
206. Banai S, Selitser V, Keren A, et al. Prospective study of bacteremia after cardiac catheterization. Am J Cardiol 2003, 92:1004-1007.
207. Munoz P, Blanco JR, Rodriguez-Creixems M, et al. Bloodstream infections after invasive nonsurgical cardiologic procedures. Arch Intern Med 2001, 161:2110-2115.
208. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001, 32:1249-1272.
209. Gonda E, Edmundson A, Mann T Late coronary stent infection: a unique complication after drug-eluting stent implantation. J Invasive Cardiol 2007, 19:E307-E308.
210. Elieson M, Mixon T, Carpenter J Coronary stent infections: a case report and literature review. Tex Heart Inst J 2012, 39:884-889.
211. Myles O, Thomas WJ, Daniels JT, et al. Infected endovascular stents managed with medical therapy alone. Catheter Cardiovasc Interv 2000, 51:471-476.
212. Ducasse E, Calisti A, Speziale F, et al. Aortoiliac stent graft infection: current problems and management. Ann Vasc Surg 2004, 18:521-526.
213. Darouiche RO Treatment of infections associated with surgical implants. N Engl J Med 2004, 350:1422-1429.
214. Sohail MR, Khan AH, Holmes DR, et al. Infectious complications of percutaneous vascular closure devices. Mayo Clin Proc 2005, 80:1011-1015.
215. Lazar JM, Ziady GM, Dummer SJ, et al. Outcome and complications of prolonged intraaortic balloon counterpulsation in cardiac patients. Am J Cardiol 1992, 69:955-958.
216. Crystal E, Borer A, Gilad J, et al. Incidence and clinical significance of bacteremia and sepsis among cardiac patients treated with intra-aortic balloon counterpulsation pump. Am J Cardiol 2000, 86:1281-1284.
217. Greenfield LJ, Proctor MC Filter complications and their management. Semin Vasc Surg 2000, 13:213-216.
218. Asciutto G, Geier B, Marpe B, et al. Dacron patch infection after carotid angioplasty: a report of 6 cases. Eur J Vasc Endovasc Surg 2007, 33:55-57.
219. Sternbergh WC Regarding "Dacron carotid patch infection: a report of eight cases.". J Vasc Surg 2001, 33:663-664.
220. Wellens F, Vanermen H Treatment of the infected cardiac suture line. J Card Surg 1988, 3:109-118.
221. Goldstein JA, Beardslee MA, Xu H, et al. Infective endocarditis resulting from CardioSEAL closure of a patent foramen ovale. Catheter Cardiovasc Interv 2002, 55:217-221.